<VariationArchive VariationID="632305" VariationName="NM_006397.3(RNASEH2A):c.206dup (p.Thr70fs)" VariationType="Duplication" Accession="VCV000632305" Version="21" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-07-29" DateCreated="2019-05-27" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="620629" VariationID="632305">
      <GeneList>
        <Gene Symbol="RNASEH2A" FullName="ribonuclease H2 subunit A" GeneID="10535" HGNC_ID="HGNC:18518" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12806584" stop="12813640" display_start="12806584" display_stop="12813640" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12917427" stop="12924461" display_start="12917427" display_stop="12924461" Strand="+" />
          </Location>
          <OMIM>606034</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006397.3(RNASEH2A):c.206dup (p.Thr70fs)</Name>
      <CanonicalSPDI>NC_000019.10:12807209:AAA:AAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12807209" stop="12807210" display_start="12807209" display_stop="12807210" variantLength="1" positionVCF="12807209" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12918023" stop="12918024" display_start="12918023" display_stop="12918024" variantLength="1" positionVCF="12918023" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>T70fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.12807212dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.12807212dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.12918026dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.12918026dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012662.1" sequenceAccession="NG_012662" sequenceVersion="1" change="g.5599dup">
            <Expression>NG_012662.1:g.5599dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006397.3" sequenceAccession="NM_006397" sequenceVersion="3" change="c.206dup" MANESelect="true">
            <Expression>NM_006397.3:c.206dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006388.2" sequenceAccession="NP_006388" sequenceVersion="2" change="p.Thr70fs">
            <Expression>NP_006388.2:p.Thr70fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_278" sequenceAccession="LRG_278">
            <Expression>LRG_278:g.5599dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_278t1" sequenceAccession="LRG_278t1">
            <Expression>LRG_278t1:c.206dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_278p1" sequenceAccession="LRG_278p1" change="p.Thr70fs">
            <Expression>LRG_278p1:p.Thr70fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006397.2" sequenceAccession="NM_006397" sequenceVersion="2" change="c.206dupA">
            <Expression>NM_006397.2:c.206dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006397.3" sequenceAccession="NM_006397" sequenceVersion="3" change="c.206dupA" MANESelect="true">
            <Expression>NM_006397.3:c.206dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="549586181" DB="dbSNP" />
      </XRefList>
      <GlobalMinorAlleleFrequency Value="0.00060" Source="1000 Genomes Project" MinorAllele="AAAA" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006397.3(RNASEH2A):c.206dup (p.Thr70fs) AND Aicardi-Goutieres syndrome 4" Accession="RCV000779252" Version="24">
        <ClassifiedConditionList TraitSetID="1274">
          <ClassifiedCondition DB="MedGen" ID="C1835912">Aicardi-Goutieres syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-01-29" SubmissionCount="5">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006397.3(RNASEH2A):c.206dup (p.Thr70fs) AND not provided" Accession="RCV001551078" Version="11">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-09-11" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006397.3(RNASEH2A):c.206dup (p.Thr70fs) AND Aicardi Goutieres syndrome" Accession="RCV001797792" Version="9">
        <ClassifiedConditionList TraitSetID="9630">
          <ClassifiedCondition DB="MedGen" ID="C0393591">Aicardi Goutieres syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-12" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2019-05-27" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(5); Likely pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">21454563</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24183309</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25274781</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25604658</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27943079</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(5); Likely pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1274" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="191" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 4</ElementValue>
                <XRef ID="MONDO:0012472" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS4</ElementValue>
                <XRef Type="MIM" ID="610333" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10896" />
                <XRef ID="10896" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15480" />
                <XRef ID="15480" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Gouti√®res syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C1835912" DB="MedGen" />
              <XRef ID="MONDO:0012472" DB="MONDO" />
              <XRef Type="MIM" ID="610333" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9630" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9456" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aicardi Goutieres syndrome</ElementValue>
                <XRef ID="230312006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, familial infantile, with calcification of basal ganglia and chronic cerebrospinal fluid lymphocytosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AGS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="575" />
                <XRef ID="575" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Gouti√®res syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C0393591" DB="MedGen" />
              <XRef ID="MONDO:0018866" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS225750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1790893" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="743648" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915816" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27943079</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25604658</ID>
          </Citation>
          <Comment>The RNASEH2A c.206dupA (p.Thr70AspfsTer50) variant results in a frameshift, and is predicted to result in premature termination of the protein. This variant has been reported in two studies and is found in one seven year old child with Aicardi-Goutieres syndrome in a homozygous state and in a family with a congenital infection-like syndrome characterized by abnormal neurological signs in a heterozygous state; no additional details are provided in the second study (Crow et al. 2015; Rice et al. 2017). Control data are not available for this variant, but it is reported at a frequency of 0.002269 in the African population of the 1000 Genomes Project. Based on the limited evidence, the p.Thr70AspfsTer50 variant is classified as a variant of unknown significance but suspicious for pathogenicity for Aicardi-Goutieres syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RNASEH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CA" referenceAllele="C" start="12918023" stop="12918023" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006397.2:c.206dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610333" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3481059" SubmissionDate="2021-08-05" DateLastUpdated="2021-08-07" DateCreated="2021-08-07">
        <ClinVarSubmissionID localKey="GDXSV:19540" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001771504" DateUpdated="2021-08-07" DateCreated="2021-08-07" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24183309)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RNASEH2A" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:737053</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006397.2:c.206dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_20_20210805063641</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3549293" SubmissionDate="2021-08-24" DateLastUpdated="2021-08-25" DateCreated="2021-08-25">
        <ClinVarSubmissionID localKey=":Chr.19_12918023_12918023_C_CA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001809376" DateUpdated="2021-08-25" DateCreated="2021-08-25" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, Amsterdam University Medical Center" OrgID="506453" OrganizationCategory="laboratory" OrgAbbreviation="VUMC GD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RNASEH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CA" referenceAllele="C" start="12918023" stop="12918023" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10240015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3861649" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-07" DateCreated="2021-10-07">
        <ClinVarSubmissionID localKey=":Chr.19_12918023_12918023_C_CA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001966252" DateUpdated="2021-10-07" DateCreated="2021-10-07" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RNASEH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CA" referenceAllele="C" start="12918023" stop="12918023" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4988111" SubmissionDate="2022-07-06" DateLastUpdated="2022-07-17" DateCreated="2022-07-17">
        <ClinVarSubmissionID localKey="NM_006397.2:c.206dup" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002548788" DateUpdated="2022-07-17" DateCreated="2022-07-17" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hhfhf6ms/nygc_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000717" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006397.2:c.206dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610333" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NYCKidSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB11741570</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5021735" SubmissionDate="2022-08-25" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="NVEM3259|MedGen:C1835912" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002567984" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="DASA" OrgID="508087" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24183309</ID>
          </Citation>
          <Comment>The c.206dup;p.(Thr70Aspfs*50) is a null frameshift variant (NMD) in the RNASEH2A gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript - PVS1.This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant(ClinVar: 632305; PMID: 24183309) - PS4. The variant is present at low allele frequencies population databases (rs549586181 ‚Äì gnomAD 0.004273%; ABraOM no frequency - https://abraom.ib.usp.br/) -PM2_supporting.The p.(Thr70Aspfs*50) was detected in trans with a pathogenic variant (PMID: 24183309) - PM3. In summary, the currently available evidence indicates that the variant is pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RNASEH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006397.3:exon 3</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="549586181" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006397.3:c.206dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1835912" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11921719</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7114270" SubmissionDate="2023-03-01" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="10595b626c07bf22def75a3cdc472502" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003806834" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PVS1 very strong, PS4 supporting, PM3 supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <Description>Paired-end whole-genome sequencing</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002273" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001347" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0012444" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000527" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0040187" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008071" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001285" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000577" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000341" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001257" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0009062" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001252" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0007371" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RNASEH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006397.3:c.206dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610333" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12925816</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1857644" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4245614|MedGen:C1835912" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000963271" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21454563</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25274781</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24183309</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr70Aspfs*50) in the RNASEH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RNASEH2A are known to be pathogenic (PMID: 21454563, 25274781). This variant is present in population databases (rs549586181, gnomAD 0.2%). This premature translational stop signal has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 24183309). ClinVar contains an entry for this variant (Variation ID: 632305). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RNASEH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.12918023_12918024insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1835912" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4005082" SubmissionDate="2024-04-03" DateLastUpdated="2024-04-15" DateCreated="2021-12-25">
        <ClinVarSubmissionID localKey="NM_006397.3:c.206dupA|MedGen:C0393591" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002041702" DateUpdated="2024-04-15" DateCreated="2021-12-25" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25604658</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24183309</ID>
          </Citation>
          <Comment>Variant summary: RNASEH2A c.206dupA (p.Thr70AspfsX50) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 7.2e-05 in 1607138 control chromosomes (gnomAD v4). The variant, c.206dupA, has been reported in the literature as a homozygous genotype in at-least one individual affected with Aicardi Goutieres Syndrome (Rice_2013). These data indicate that the variant likely associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 632305). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RNASEH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006397.3:c.206dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0393591" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10828019</SubmissionName>
          <SubmissionName>SUB14342304</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4005082" TraitType="Disease" MappingType="XRef" MappingValue="C0393591" MappingRef="MedGen">
        <MedGen CUI="C0393591" Name="Aicardi Goutieres syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4988111" TraitType="Disease" MappingType="XRef" MappingValue="610333" MappingRef="OMIM">
        <MedGen CUI="C1835912" Name="Aicardi-Goutieres syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4988111" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001285" MappingRef="HP">
        <MedGen CUI="C0575059" Name="Spastic tetraparesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790893" TraitType="Disease" MappingType="XRef" MappingValue="610333" MappingRef="OMIM">
        <MedGen CUI="C1835912" Name="Aicardi-Goutieres syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000527" MappingRef="HP">
        <MedGen CUI="C1853738" Name="Long eyelashes" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0009062" MappingRef="HP">
        <MedGen CUI="C3806604" Name="Infantile axial hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3861649" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3481059" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000577" MappingRef="HP">
        <MedGen CUI="C0015310" Name="Exotropia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5021735" TraitType="Disease" MappingType="XRef" MappingValue="C1835912" MappingRef="MedGen">
        <MedGen CUI="C1835912" Name="Aicardi-Goutieres syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012444" MappingRef="HP">
        <MedGen CUI="C4551584" Name="Brain atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0040187" MappingRef="HP">
        <MedGen CUI="C0456103" Name="Neonatal sepsis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007371" MappingRef="HP">
        <MedGen CUI="C0431370" Name="Corpus callosum atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Disease" MappingType="XRef" MappingValue="610333" MappingRef="OMIM">
        <MedGen CUI="C1835912" Name="Aicardi-Goutieres syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001252" MappingRef="HP">
        <MedGen CUI="C0026827" Name="Hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000341" MappingRef="HP">
        <MedGen CUI="C1839758" Name="Narrow forehead" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002273" MappingRef="HP">
        <MedGen CUI="C0270790" Name="Tetraparesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3549293" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4988111" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001263" MappingRef="HP">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1857644" TraitType="Disease" MappingType="XRef" MappingValue="C1835912" MappingRef="MedGen">
        <MedGen CUI="C1835912" Name="Aicardi-Goutieres syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008071" MappingRef="HP">
        <MedGen CUI="C0565599" Name="Maternal hypertension" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001257" MappingRef="HP">
        <MedGen CUI="C0026838" Name="Spasticity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7114270" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001347" MappingRef="HP">
        <MedGen CUI="C0151889" Name="Hyperreflexia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4988111" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000717" MappingRef="HP">
        <MedGen CUI="C0004352" Name="Autism" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001528559</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2023-05-04">SCV003807613</Accession>
        <Description>The interpretation was submitted with an incorrect phenotype.</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

